Targeting the tumour microenvironment with an enzyme-responsive drug delivery system for the efficient therapy of breast and pancreatic cancers
出版年份 2017 全文链接
标题
Targeting the tumour microenvironment with an enzyme-responsive drug delivery system for the efficient therapy of breast and pancreatic cancers
作者
关键词
-
出版物
Chemical Science
Volume 8, Issue 5, Pages 3427-3433
出版商
Royal Society of Chemistry (RSC)
发表日期
2017-03-08
DOI
10.1039/c7sc00472a
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bioresponsive materials
- (2016) Yue Lu et al. Nature Reviews Materials
- Self-Immolative Spacers: Kinetic Aspects, Structure-Property Relationships, and Applications
- (2015) Ahmed Alouane et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Antibody-Drug Conjugates: An Emerging Concept in Cancer Therapy
- (2014) Ravi V. J. Chari et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- β-Glucuronidase-responsive prodrugs for selective cancer chemotherapy: An update
- (2014) Isabelle Tranoy-Opalinski et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Selective Release of a Cyclopamine Glucuronide Prodrug toward Stem-like Cancer Cell Inhibition in Glioblastoma
- (2014) A. Balbous et al. MOLECULAR CANCER THERAPEUTICS
- Efficient Human Breast Cancer Xenograft Regression after a Single Treatment with a Novel Liposomal Formulation of Epirubicin Prepared Using the EDTA Ion Gradient Method
- (2014) Jerzy Gubernator et al. PLoS One
- Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance
- (2013) Zhishen Ge et al. CHEMICAL SOCIETY REVIEWS
- Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast Cancer
- (2013) D. A. Proia et al. CLINICAL CANCER RESEARCH
- Synthesis and biological evaluations of a monomethylauristatin E glucuronide prodrug for selective cancer chemotherapy
- (2013) Thibaut Legigan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Selective Cancer Therapy by Extracellular Activation of a Highly Potent Glycosidic Duocarmycin Analogue
- (2013) Kai-Chuan Chen et al. MOLECULAR PHARMACEUTICS
- The First Generation of β-Galactosidase-Responsive Prodrugs Designed for the Selective Treatment of Solid Tumors in Prodrug Monotherapy
- (2012) Thibaut Legigan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Synthesis and Antitumor Efficacy of a β-Glucuronidase-Responsive Albumin-Binding Prodrug of Doxorubicin
- (2012) Thibaut Legigan et al. JOURNAL OF MEDICINAL CHEMISTRY
- The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
- (2012) Peter D Senter et al. NATURE BIOTECHNOLOGY
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of albumin on drug delivery — New applications on the horizon
- (2011) Bakheet Elsadek et al. JOURNAL OF CONTROLLED RELEASE
- A new cyclopamine glucuronide prodrug with improved kinetics of drug release
- (2011) Brigitte Renoux et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Phenotype and Genotype of Pancreatic Cancer Cell Lines
- (2010) Emily L. Deer et al. PANCREAS
- Antiangiogenesis Targeting Tumor Microenvironment Synergizes Glucuronide Prodrug Antitumor Activity
- (2009) T.-Y. Juan et al. CLINICAL CANCER RESEARCH
- 2-Deoxy-d-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer
- (2007) Mitchell C. Coleman et al. FREE RADICAL BIOLOGY AND MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now